152 related articles for article (PubMed ID: 20022787)
1. Childhood scleromyositis with a negative PM/Scl antibody.
Marcus M; Ilyas M; Tolaymat A
Joint Bone Spine; 2010 Jan; 77(1):73-5. PubMed ID: 20022787
[TBL] [Abstract][Full Text] [Related]
2. Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody.
Błaszczyk M; Jabłońska S; Szymańska-Jagiełło W; Jarzabek-Chorzelska M; Chorzelski T; Mohamed AH
Pediatr Dermatol; 1991 Mar; 8(1):1-8. PubMed ID: 1907368
[TBL] [Abstract][Full Text] [Related]
3. Childhood sclerodermatomyositis: report of a case with the anti-PM/Scl antibody and mechanic's hands.
García-Patos V; Bartralot R; Fonollosa V; Arnal C; Boronat M; Gelpí C; Rodríguez JL; Castells A
Br J Dermatol; 1996 Oct; 135(4):613-6. PubMed ID: 8915158
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma overlap syndromes.
Jablonska S; Blaszczyk M
Adv Exp Med Biol; 1999; 455():85-92. PubMed ID: 10599327
[TBL] [Abstract][Full Text] [Related]
5. Childhood sclerodermatomyositis with generalized morphea.
Ambade GR; Dhurat RS; Lade N; Jerajani HR
Indian J Dermatol Venereol Leprol; 2008; 74(2):148-50. PubMed ID: 18388377
[TBL] [Abstract][Full Text] [Related]
6. Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients.
Vandergheynst F; Ocmant A; Sordet C; Humbel RL; Goetz J; Roufosse F; Cogan E; Sibilia J
Clin Exp Rheumatol; 2006; 24(2):129-33. PubMed ID: 16762146
[TBL] [Abstract][Full Text] [Related]
7. A Japanese patient with anti-PM/Scl and centromere antibody-positive scleroderma-amyopathic dermatomyositis overlap syndrome who developed renal crisis.
Nishida T; Nakano K; Satoh M; Fukuyo S; Akashi K; Tanaka Y
Mod Rheumatol Case Rep; 2022 Jan; 6(1):69-74. PubMed ID: 34506625
[TBL] [Abstract][Full Text] [Related]
8. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
9. [Antinucleolar antibodies in diagnostics of antiphospholipid syndrome].
Zabek J; Palacz A; Pyka J; Krzewska I
Pol Arch Med Wewn; 2008; 118 Suppl():25-30. PubMed ID: 19562966
[TBL] [Abstract][Full Text] [Related]
10. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour AM; Zarka F; Makhzoum JP; Nehme J; Rich E; Goulet JR; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal JL
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
[TBL] [Abstract][Full Text] [Related]
11. A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies.
Gutiérrez-Ramos R; Gonz Lez-Díaz V; Pacheco-Tovar MG; López-Luna A; Avalos-Díaz E; Herrera-Esparza R
Reumatismo; 2008; 60(4):296-300. PubMed ID: 19132155
[TBL] [Abstract][Full Text] [Related]
12. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
Mahler M; Raijmakers R
Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
[TBL] [Abstract][Full Text] [Related]
13. Immunological markers of the subsets of systemic scleroderma and its overlap.
Jabłońska S; Błaszczyk M; Jarzabek-Chorzelska M; Chorzelski T; Kołacińska-Strasz Z
Arch Immunol Ther Exp (Warsz); 1991; 39(4):381-90. PubMed ID: 1821614
[TBL] [Abstract][Full Text] [Related]
14. Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis.
Giannini M; Ellezam B; Leclair V; Lefebvre F; Troyanov Y; Hudson M; Senécal JL; Geny B; Landon-Cardinal O; Meyer A
Front Immunol; 2022; 13():974078. PubMed ID: 36776390
[TBL] [Abstract][Full Text] [Related]
15. [Polymyositis/scleroderma autoantibody-positive scleroderma with dermatomyositis (scleromyositis)].
Török L; Dankó K; Cserni G; Szücs G
Orv Hetil; 2002 Nov; 143(45):2553-6. PubMed ID: 12501562
[TBL] [Abstract][Full Text] [Related]
16. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH
J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149
[TBL] [Abstract][Full Text] [Related]
17. [Anti PM-Scl antibodies. Study of prevalence and of meaning].
Gaudin C; Fortenfant F; Adoue D; Beyne-Rauzy O
Rev Med Interne; 2006 Sep; 27(9):665-70. PubMed ID: 16797795
[TBL] [Abstract][Full Text] [Related]
18. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
[TBL] [Abstract][Full Text] [Related]
19. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
Zitnan D; Rovenský J; Cebecauer L; Hajzok O
Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
[No Abstract] [Full Text] [Related]
20. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
